Europlasma S.A. (EPA:ALEUP)

Europlasma Statistics

Total Valuation

Europlasma has a market cap or net worth of EUR 106,317. The enterprise value is 4.98 million.

Market Cap	106,317
Enterprise Value	4.98M

Important Dates

The next estimated earnings date is Wednesday, April 29, 2026.

Earnings Date	Apr 29, 2026
Ex-Dividend Date	n/a

Share Statistics

Europlasma has 2.59 million shares outstanding.

Current Share Class	2.59M
Shares Outstanding	2.59M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.00
PB Ratio	-0.01
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-0.11
EV / Sales	0.08
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-0.19

Financial Position

The company has a current ratio of 0.80

Current Ratio	0.80
Quick Ratio	0.42
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-0.66
Interest Coverage	-3.29

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-22.66%
Return on Invested Capital (ROIC)	-351.37%
Return on Capital Employed (ROCE)	-164.80%
Weighted Average Cost of Capital (WACC)	34.88%
Revenue Per Employee	151,116
Profits Per Employee	-111,761
Employee Count	398
Asset Turnover	0.78
Inventory Turnover	1.80

Taxes

Income Tax	-2.13M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -99.86% in the last 52 weeks. The beta is -113.20, so Europlasma's price volatility has been lower than the market average.

Beta (5Y)	-113.20
52-Week Price Change	-99.86%
50-Day Moving Average	0.20
200-Day Moving Average	7.30
Relative Strength Index (RSI)	25.24
Average Volume (20 Days)	2,164,560

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Europlasma had revenue of EUR 60.14 million and -44.48 million in losses. Loss per share was -320.40.

Revenue	60.14M
Gross Profit	26.10M
Operating Income	-27.94M
Pretax Income	-48.33M
Net Income	-44.48M
EBITDA	-16.05M
EBIT	-27.94M
Loss Per Share	-320.40

Balance Sheet

The company has 10.51 million in cash and 17.25 million in debt, with a net cash position of -6.73 million or -2.60 per share.

Cash & Cash Equivalents	10.51M
Total Debt	17.25M
Net Cash	-6.73M
Net Cash Per Share	-2.60
Equity (Book Value)	-20.80M
Book Value Per Share	-33.86
Working Capital	-13.48M

Cash Flow

In the last 12 months, operating cash flow was -22.60 million and capital expenditures -3.53 million, giving a free cash flow of -26.13 million.

Operating Cash Flow	-22.60M
Capital Expenditures	-3.53M
Free Cash Flow	-26.13M
FCF Per Share	-10.08

Margins

Gross margin is 43.39%, with operating and profit margins of -46.46% and -73.96%.

Gross Margin	43.39%
Operating Margin	-46.46%
Pretax Margin	-80.36%
Profit Margin	-73.96%
EBITDA Margin	-26.68%
EBIT Margin	-46.46%
FCF Margin	n/a

Dividends & Yields

Europlasma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-41,838.09%
FCF Yield	-24,577.44%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on October 7, 2025. It was a reverse split with a ratio of 0.0004.

Last Split Date	Oct 7, 2025
Split Type	Reverse
Split Ratio	0.0004

Scores

Europlasma has an Altman Z-Score of -4.76 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.76
Piotroski F-Score	2